ALDX
Aldeyra Therapeutics Inc.
Company Overview
| Mkt Cap | $295.29M | Price | $5.07 |
| Volume | 568.80K | Change | +0.80% |
| P/E Ratio | -5.3 | Open | $5.01 |
| Revenue | -- | Prev Close | $5.03 |
| Net Income | $-55.9M | 52W Range | $1.14 - $7.20 |
| Div Yield | N/A | Target | $9.00 |
| Overall | 38 | Value | 50 |
| Quality | 28 | Technical | 36 |
No chart data available
Stock Overview
Updated DailyAldeyra Therapeutics Inc. (ALDX) is a leading Healthcare company in the Biotechnology industry, currently trading at $5.07 with a market capitalization of $295.29 million. The stock is positioned in the upper portion of its trading range, demonstrating concerning quality fundamentals with a MarketXLS quality score of 28.
Today's trading session shows ALDX with a volume of 569K shares. The stock opened down 0.40% from yesterday's close of $5.03. Current analyst estimates project earnings of $-0.69 per share for this year, with next year targeting $0.88.
ALDX demonstrates concerning technical signals based on technical analysis. The company trades on the NSC exchange and operates alongside industry peers including ANTH, TENX, REGN.
Key investment considerations for ALDX include concerning overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 77.5%. The stock shows neutral valuation indicators based on valuation analysis.
Analysis generated on November 3, 2025 at 07:11 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ALDX | $5.07 | +0.8% | 568.80K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Aldeyra Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW